EUVIMEDEUVIMED entdecken
Crossref

Reassessing Age as a Barrier: Real-World Evidence of Chemotherapy and Immunotherapy in Older Adults

Haider Imran, Zahra Ali Haque, Muhammad Owais Mazhar, Muhammad Aatir Aslam

Malignancy Spectrum · 2026 · 3 (2) · 89

DOI: 10.15302/msp.2026.0009 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Malignancy Spectrum, 2026. Verfasst von Haider Imran und 3 weiteren Autor:innen. Die Arbeit nennt 4 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Imran, H., Haque, Z. A., Mazhar, M. O., & Aslam, M. A. (2026). Reassessing Age as a Barrier: Real-World Evidence of Chemotherapy and Immunotherapy in Older Adults. Malignancy Spectrum, 3(2), 89. https://doi.org/10.15302/msp.2026.0009

Vancouver

Imran H, Haque ZA, Mazhar MO, Aslam MA. Reassessing Age as a Barrier: Real-World Evidence of Chemotherapy and Immunotherapy in Older Adults. Malignancy Spectrum. 2026;3(2):89. doi:10.15302/msp.2026.0009

BibTeX
@article{Imran2026,
  author = {Imran, Haider and Haque, Zahra Ali and Mazhar, Muhammad Owais and Aslam, Muhammad Aatir},
  title = {Reassessing Age as a Barrier: Real-World Evidence of Chemotherapy and Immunotherapy in Older Adults},
  journal = {Malignancy Spectrum},
  year = {2026},
  volume = {3},
  number = {2},
  pages = {89},
  doi = {10.15302/msp.2026.0009}
}
Kostenlos starten →